✦ LIBER ✦

Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma

✍ Scribed by Pönisch, Wolfram; Holzvogt, Bruno; Plötze, Madlen; Andrea, Marc; Bourgeois, Malvina; Heyn, Simone; Zehrfeld, Thomas; Hammerschmidt, Doreen; Schwarz, Maik; Edelmann, Thomas; Becker, Cornelia; Hoffmann, Franz Albert; Schwarzer, Andreas; Kreibich, Ute; Gutsche, Kerstin; Reifenrath, Kolja; Winkelmann, Cornelia; Krahl, Rainer; Remane, Yvonne; Hennig, Evelin; Schliwa, Thomas; Lindner, Tom; Kaiser, Thorsten; Vucinic, Vladan; Behre, Gerhard; Niederwieser, Dietger

Book ID: 125347661
Publisher: Springer-Verlag
Year: 2014
Tongue: English
Weight: 331 KB
Volume: 140
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-014-1737-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined bendamustine, prednisone and bo

Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma

✍ Wolfram Pönisch, Malvina Bourgeois… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 303 KB

Successful treatment of patients with ne

Successful treatment of patients with newly diagnosed/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone

✍ Wolfram Pönisch, Marc Andrea, Ina Wagner, Doreen Hammerschmidt, Ute Kreibich, An 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 349 KB

Bendamustine and prednisone in combinati

Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure

✍ Pönisch, Wolfram; Moll, Barbara; Bourgeois, Malvina; Andrea, Marc; Schliwa, Thom 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 336 KB

Bortezomib, melphalan, and prednisone ve

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial

✍ María-Victoria Mateos; Albert Oriol; Joaquín Martínez-López; Norma Gutiérrez; An 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 255 KB

Bortezomib and thalidomide, a steroid fr

Bortezomib and thalidomide, a steroid free regimen in newly diagnosed patients with multiple myeloma

✍ Nilanjan Ghosh; Xiaobu Ye; Anna Ferguson; Carol Ann Huff; Ivan Borrello 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Bortezomib in combination with dexametha

Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience

✍ Weiyan Zheng; Guoqing Wei; Xiujin Ye; Jingsong He; Li Li; Wenjun Wu; Jimin Shi; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 245 KB

## Objective: Bortezomib-dexamethasone-thalidomide has been reported to be effective in newly-diagnosed multiple myeloma (mm) with an overall response rate of 92% and a cr rate of 18% (alexanian et al, hematology 2007;12(3):235-9), but this regimen has not been tested in the chinese patients. we re